Javascript must be enabled to continue!
Metformin: A Versatile Therapeutic Agent in Various Diseases and Health Conditions
View through CrossRef
Metformin, a widely used medication for type 2 diabetes, has therapeutic effects beyond glycemic control. This literature review provides a comprehensive summary of metformin's mechanisms, clinical applications, and research progress in various health conditions, including its potential role in the management of COVID-19. The review covers the historical development of metformin and its efficacy in treating diabetes. It explores its mechanisms of action, including blood glucose reduction and improved insulin resistance. Furthermore, the review discusses metformin's applications in obesity, metabolic disorders, cancer, and cardiovascular disease. It highlights its potential to facilitate weight loss, decrease liver glucose output, enhance muscle glucose uptake, and contribute to cancer prevention and treatment. Additionally, metformin's protective effects against cardiovascular disease are addressed. Moreover, the review explores emerging research on metformin's anti-aging, anti-inflammatory, and antioxidant properties, expanding its therapeutic potential. This comprehensive review emphasizes metformin's significant therapeutic potential in various health conditions, including its potential role in the management of COVID-19. It calls for further investigation to better understand its mechanisms of action and optimize its clinical applications.
Title: Metformin: A Versatile Therapeutic Agent in Various Diseases and Health Conditions
Description:
Metformin, a widely used medication for type 2 diabetes, has therapeutic effects beyond glycemic control.
This literature review provides a comprehensive summary of metformin's mechanisms, clinical applications, and research progress in various health conditions, including its potential role in the management of COVID-19.
The review covers the historical development of metformin and its efficacy in treating diabetes.
It explores its mechanisms of action, including blood glucose reduction and improved insulin resistance.
Furthermore, the review discusses metformin's applications in obesity, metabolic disorders, cancer, and cardiovascular disease.
It highlights its potential to facilitate weight loss, decrease liver glucose output, enhance muscle glucose uptake, and contribute to cancer prevention and treatment.
Additionally, metformin's protective effects against cardiovascular disease are addressed.
Moreover, the review explores emerging research on metformin's anti-aging, anti-inflammatory, and antioxidant properties, expanding its therapeutic potential.
This comprehensive review emphasizes metformin's significant therapeutic potential in various health conditions, including its potential role in the management of COVID-19.
It calls for further investigation to better understand its mechanisms of action and optimize its clinical applications.
Related Results
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract
BACKGROUND
Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer agent...
Abstract PO1-05-11: Efficacy of metformin as adjunctive therapy in patients with de novo metastatic breast cancer: a retrospective cohort study
Abstract PO1-05-11: Efficacy of metformin as adjunctive therapy in patients with de novo metastatic breast cancer: a retrospective cohort study
Abstract
Background: Metformin, an oral biguanide used for the treatment of type-2 diabetes mellitus (DM), has been shown in a considerable number of studies to have...
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract
Introduction and Objective. Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer age...
Morning exercise and pre-breakfast metformin interact to reduce glycaemia in people with Type 2 Diabetes: a randomized crossover trial
Morning exercise and pre-breakfast metformin interact to reduce glycaemia in people with Type 2 Diabetes: a randomized crossover trial
Abstract
Exercise is recommended in the treatment of Type 2 Diabetes and can improve insulin sensitivity [1]. However, previous evidence suggests that exercise at d...
Vitamin B12 Status in Metformin Treated Diabetics: Cross Sectional Study
Vitamin B12 Status in Metformin Treated Diabetics: Cross Sectional Study
Background: Metformin is the most commonly used drug for patients with type 2 diabetes mellitus (T2DM) patients. Metformin related vitamin B12 deficiency can cause anemia. Accordin...
867 Postoperative Metformin is Associated With Improved Survival of Glioblastoma Patients
867 Postoperative Metformin is Associated With Improved Survival of Glioblastoma Patients
INTRODUCTION:
Metformin may improve clinical outcomes for glioblastoma (GBM) patients as metformin showed in vitro tumor suppressor functions, such as reducing the prol...
Kajian Interaksi Obat Metformin pada Pasien Diabetes Mellitus
Kajian Interaksi Obat Metformin pada Pasien Diabetes Mellitus
Diabetes melitus merupakan penyakit degeneratif kronis yang apabila tidak ditangani dengan tepat, lama kelamaan bisa timbul berbagai komplikasi, ini cenderung menyebabkan pasien me...
Metformin mediates AMPK/KIF1B signalling pathway to inhibit metastasis in bladder cancer cells
Metformin mediates AMPK/KIF1B signalling pathway to inhibit metastasis in bladder cancer cells
Abstract
Background
To investigate the inhibitory effect of metformin on metastasis of bladder cancer cells and its potential mechanism.
Methods
The CCK-8 method and RTCA...

